Intersect ENT presents a case-study based discussion on strategies for maximizing sinus surgery outcomes. Discussions led by Dr. Jivianne Lee (University of California, Los Angeles) and Dr. Greg Davis (University of Washington) will include strategies for management of post-operative inflammation with localized drug delivery in the frontal and maxillary sinus ostia.
This is a non-CME event sponsored by Intersect ENT. The views expressed by the speakers do not necessarily reflect that of the American Rhinologic Society. The American Rhinologic Society is not endorsing any company or product.
Greg E. Davis, M.D., M.P.H., is currently an associate professor of otolaryngology at the University of Washington. He is the director of rhinology and endoscopic skull base surgery. Dr. Davis earned his medical degree from the University of Washington's School of Medicine, then completed a seven year residency in otolaryngology - head and neck surgery at the University of Washington. During his residency, he completed a two year clinical research fellowship where he earned his Master's in Public Health, a degree when he focused on clinical trial design and management, biostatistics, and epidemiology. After residency, he traveled to Adelaide Australia and spent additional time training with P.J. Wormald, a world-renowned rhinologist.
Dr. Lee is a Clinical Assistant Professor at UCLA. She received her medical degree followed by an Otolaryngology Residency at UCLA. She completed her Rhinology Fellowship with Dr. David Kennedy at The University of Pennsylvania. She is the founder and Co-Director of the Orange County Sinus Institute in Irvine, CA.